UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000014262
Receipt No. R000016611
Scientific Title Investigation of dexmedetomidine concentration in breast milk during postpartum period
Date of disclosure of the study information 2014/06/13
Last modified on 2021/04/19 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Investigation of dexmedetomidine concentration in breast milk during postpartum period
Acronym Investigation of dexmedetomidine concentration in breast milk during postpartum period
Scientific Title Investigation of dexmedetomidine concentration in breast milk during postpartum period
Scientific Title:Acronym Investigation of dexmedetomidine concentration in breast milk during postpartum period
Region
Japan

Condition
Condition pregnant women undergo elective cesarean section
Classification by specialty
Obsterics and gynecology Anesthesiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To estimate the transfer of dexmedetomidine into breast milk after cesarean section
Basic objectives2 Pharmacokinetics
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase Not applicable

Assessment
Primary outcomes dexmedetomidine concentration in breast milk
Key secondary outcomes dexmedetomidine concentration in blood
neonatal assessment

Base
Study type

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 regulatory administration of dexmedetomidine after delivery for cesarean section
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit
40 years-old >=
Gender Female
Key inclusion criteria normal pregnant women undergo elective cesarean section
Key exclusion criteria patientrefusal
serious preexisting condition
massive bleeding
unexpected vital change
Target sample size 10

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Manabu Yoshimura
Organization Tokuyama Central hospital
Division name department of anesthesiology
Zip code
Address 1-1 kodacyo, Shunan 745-8522, Japan
TEL 0834-28-4411
Email manabu-ygc@umin.ac.jp

Public contact
Name of contact person
1st name
Middle name
Last name Manabu Yoshimura
Organization Tokuyama Central Hospital
Division name department of anesthesiology
Zip code
Address 1-1 Kodacyo, Shunan 745-8522, Japan
TEL 0834-28-4411
Homepage URL
Email chiken2@tokuchuhp.jp

Sponsor
Institute Tokuyama Central Hospital
Institute
Department

Funding Source
Organization Tokuyama Central Hospital
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2014 Year 06 Month 13 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2014 Year 05 Month 08 Day
Date of IRB
2014 Year 05 Month 16 Day
Anticipated trial start date
2014 Year 06 Month 13 Day
Last follow-up date
2015 Year 10 Month 13 Day
Date of closure to data entry
2015 Year 10 Month 13 Day
Date trial data considered complete
2015 Year 12 Month 16 Day
Date analysis concluded
2015 Year 12 Month 16 Day

Other
Other related information

Management information
Registered date
2014 Year 06 Month 13 Day
Last modified on
2021 Year 04 Month 19 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016611